Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation
Clinical trial NCT01491178 · COMPLETED
Trial details
- NCT number
- NCT01491178
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-12-12
- Primary completion
- 2016-08-02
- Enrollment
- 6772
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.